Wells Fargo upgraded the MedTech company Zimmer Biomet Holdings (ZBH) to Equal Weight from Underweight on Wednesday, noting, among other things, improving market trends for orthopedics…

NEW YORK, Nov. 23, 2022 /PRNewswire/ -- Major players in the ai-based surgical robots market are Accuray Incorporated, Intuitive Surgical Inc, Medtronic plc, Medrobotics Corporation, Zimmer Biomet, Stereotaxis Inc, TransEnterix Inc , Stryker Corporation, Activ Surgical Inc, Titan Medical…

https://www.investing.com/news/pro/wells-fargo-upgrades-zimmer-biomet-to-equal-weight-432SI-2950610

WARSAW, Ind., Nov. 21, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Executive Management Team will present at the 34th Annual Piper Sandler Healthcare Conference on Thursday, December 1,…

The U.S. Food and Drug Administration ((FDA)) granted 510(k) clearance to Zimmer Biomet''s (ZBH) Persona OsseoTi Keel Tibia for cementless knee replacement.The device is an addition to…

-- New Porous Iteration of Anatomic Keeled Tibia Designed to Deliver Stable Initial and Biological Fixation Together with the Clinically Proven Benefits of the Persona Knee System -- WARSAW, Ind., Nov. 21, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global…

Offices - River Development, the developer of Sema Parc and The Light projects, announces the lease of office space to Zimmer Biomet Romania in the Paris office

River Development, the developer of Sema Parc and The Light projects, announces the lease of office space to Zimmer Biomet Romania in the Paris office building in Sema Parc. Zimmer Biomet Holdings is opening its first branch in Romania and is investing more than €3.5 million in our country in 2023. The investment will go towards logistical expenses (new office, warehouse, etc.), building the local team and securing equipment stock. The company will move from distributor representation to direct representation, and this change will mean expanding its product portfolio, medical education offering and introducing a number of integrated digital and robotic technologies to the Romanian market. With the opening of the new office in Sema Parc, Romanian patients will have access to Zimmer Biomet’s latest and most modern products, a wider range of solutions for sports medicine, joint and extremity reconstruction, as well as the company’s digital and robotic technologies. The ZBEdge range combines integrated digital technologies, implants, robotics and monitoring services, providing a unique medical platform in orthopaedics.

Related Stocks: TT , ARE , BURL , ZBH , LKQ ,

WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings Inc. (ZBH) said one-year data from mymobility clinical study showed that using mymobility with Apple Watch following primary knee arthroplasty, common…

Zimmer Biomet Holdings, Inc. (NYSE:NYSE:ZBH) Q3 2022 Earnings Conference Call November 02, 2022 08:30 AM ET Company Participants Keri Mattox - Senior Vice President, Chief Communications…

Zimmer Biomet Holdings Inc. (NYSE:ZBH) has a beta value of 1.08 and has seen 0.73 million shares traded in the recent trading session. The company, currently valued at $23.07B, closed the recent trade at $112.62 per share which meant it gained $0.78 on the day or 0.70% during that session. The ZBH stock price is … Weak Fundamental Momentum Drags Zimmer Biomet Holdings Inc. (ZBH) Upper Read More »

https://www.investing.com/news/pro/zimmer-biomet-pt-raised-to-128-at-evercore-isi-432SI-2929635

Zimmer Biomet Earnings, Revenue Beat in Q3

WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings Inc. (ZBH) announced a profit for its third quarter that increased from the same period last yearThe company''s earnings came in at $194.0 million, or …

Zimmer Biomet Holdings Tops Q3 EPS by 2c; Bumps FY Outlook Higher

Zimmer Biomet Holdings (NYSE: ZBH ) reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:30 AM. Here''s what investors need to know about the announcement. Earnings Zimmer Biomet Holdings beat estimated earnings by 1.28%, reporting an EPS of $1.58 … Full story available on Benzinga.com

Zimmer Biomet press release (ZBH): Q3 Non-GAAP EPS of $1.58 beats by $0.02.Revenue of $1.67B (-1.2% Y/Y) beats by $30M.Company updates 2022 financial guidance, raising range for…

Zimmer Biomet (ZBH) is scheduled to announce Q3 earnings results on Wednesday, November 2nd, before market open.The consensus EPS Estimate is $1.56 (-13.8% Y/Y) and the consensus Revenue…

Related Stocks: PG , ZBH , NVS , XOM , AMED ,

Zimmer Biomet Holdings with ticker code (ZBH) now have 22 analysts in total covering the stock. The consensus rating is ''Hold''. The range between the high target price and low target price is between 145 and 95 with a mean TP of 124.05. With the stocks previous close at 106.33 this would imply there is a potential upside of 16.7%. The 50 day moving average now sits at 110.09 and the 200 day MA is 115.52. The company has a market cap of $22,912m. You can visit the company''s website by visiting: https://www.zimmerbiomet.com [stock_market_widget type="chart" template="basic" color="green" assets="ZBH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $26,730m based on the market concensus. Zimmer Biomet Holdings, together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.

Bioresorbable Implants Market Research focuses on the key trends prevailing in the Global Bioresorbable Implants Industry sector. The existing Industry scenario has been studied and future projections with respect to the sector have also been investigated. Market study report

https://www.investing.com/news/pro/jefferies-starts-zimmer-biomet-at-underperform-432SI-2909908

WARSAW, Ind., Oct. 5, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Wednesday, November 2, 2022 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that…

WILMINGTON, DE / ACCESSWIRE / October 5, 2022 / Transparency Market Research Inc. - The emergence of new types of implants, made from combination of various materials to offer enhanced lifespan and exceptional stability are anticipated to propel growth in the global hip replacement implants market in coming years. At present, a high number of patients suffering from arthritis opt for hip replacement surgeries. Some other key reasons for undergoing hip replacement surgery include hip fracture, as well as wear and tear of the hip. According to a recent research report, the global hip replacement implants market is anticipated to register a CAGR of 4% over the forecast period of 2021 to 2031. Hip Replacement Implants Market - Key Findings of the Report Increasing demand for Metal-on-Polyethylene Materials : Players in the global hip replacement implants market offer products and solutions manufactured using various types of bio-compatible materials. These include metal on metal, ceramic on metal, ceramic on ceramic, metal on polyethylene, and ceramic on polyethylene.

Zimmer Biomet, a pioneer in making medical devices, is joining hands with Network18 to promote awareness about arthritis and bone health.